Interferon type I gene expression in chronic hepatitis C. - Wikidata - wikimedia - TriplyDB

Interferon type I gene expression in chronic hepatitis C.

Interferon type I gene expression in chronic hepatitis C.

http://www.wikidata.org/entity/Q34328120

about

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients Innate immune evasion by hepatitis C virus and West Nile virus Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis.IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs.Interferon-λ in HCV Infection and Therapy.Hepatitis C virus reveals a novel early control in acute immune response.The induction of type I interferon production in hepatitis C-infected patients.Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV.The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.Long Non-Coding RNA BST2/BISPR is Induced by IFN and Regulates the Expression of the Antiviral Factor Tetherin.Hepatitis C virus virology and new treatment targets.Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.IFN-Alpha receptor-1 upregulation in PBMC from HCV naïve patients carrying cc genotype. possible role of IFN-lambda.Interferon lambdas: the next cytokine storm Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function.dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection.Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity.Interferon Lambda: Modulating Immunity in Infectious Diseases.Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.IFN-λs.A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects.IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patients.The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure.Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses.Unconjugated interferon-stimulated gene 15 specifically interacts with the hepatitis C virus NS5A protein via domain I.IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis.Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy.Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.Immune responses induced by intranasal imiquimod and implications for therapeutics in rhinovirus infections.

P2860

Q24815995-10F185DD-D29D-4DFD-95FA-76C13A45E253 Q27482532-C7E6FB1D-D50C-49ED-8DC8-E91E9B9E5EB5 Q27489865-792D8475-B105-4493-ABF1-8704B504D4D0 Q33214445-B8A5A734-99FC-4EED-928B-4D7790E98B64 Q33586624-BBBD9834-AEB4-4670-95CE-C9782344522B Q33775597-2D476564-D996-43C8-B841-69BB8D72A53C Q33826704-99C1D39F-16C5-43E3-8E03-5F2FD1C72EFF Q34047500-A662A746-0244-4EA1-9BD9-FF8DE4D3F771 Q34055291-08669E78-05FB-4442-AFD3-0298B621D5F1 Q34208032-C70C5C82-5350-4F44-B6B1-3EC1648F73B0 Q34433087-AF395D3B-3445-413B-BA6D-69DD9AEF3024 Q34575747-E50B6A00-CAAA-4E18-A3B7-2A4416AF0700 Q34647423-3E1C501E-42AE-48B0-A68E-F89772F79E83 Q34750577-41224225-D37E-4824-8F3A-777AB33F92F4 Q34885158-A476EE15-D757-484A-99FB-B14FE893DC36 Q34974042-B7D3F3ED-F965-4EA6-8A9F-F163301DEBC3 Q35078322-DC4CB19A-E441-491A-8B37-05E0093DFF50 Q35137523-CD704C84-EFA6-41C1-B6B4-EA6A80F4226A Q35154826-76497409-8CDB-4615-BB63-8ABBE68F4954 Q35852736-E2509653-9E24-4D9C-8C30-42645F32EB05 Q36104804-B39F3320-3910-46B1-B375-DE24E099D366 Q36432681-B1881439-8C62-4F1F-80BC-E5672F7F0F6B Q37255268-256F7C35-C36C-4623-B53B-11AE8A7AA623 Q37670446-C15F786E-A2C4-4645-9507-906564C41CBD Q37774371-E232168A-B862-48CD-9C3F-7D015CDD14D9 Q37917252-26374136-9221-4DE1-9A01-2B1C76270F93 Q37947594-E0E3D365-DB1A-44F1-9527-00DCFB5D443C Q38053543-6C22E55E-9C2B-489D-8F22-4B0EF623527F Q38297424-8FC6B2CC-E2A7-4145-BD68-51DCF3DC6145 Q38514365-0D28FAB3-8DF9-483F-A508-1CC821B1AF51 Q38628070-54CAC444-D130-4F55-96C2-128265AF8EBA Q38859455-1B702D66-B21A-4A46-9910-EFE1B1D0796B Q39159184-EC97560E-6B37-41CA-B062-57178E2A6E7C Q39590657-991ADE4B-2AB4-4C1E-96E5-FBDC4280E4D2 Q40185810-4066AA78-903B-4C02-979D-DB63A4C44B2B Q42247379-19A142D9-4B3A-45CB-A19E-22D5E39336A6 Q43036965-9DF47AE1-5D53-452A-9306-A061D88E39DD Q43048075-F6E9ACF8-357E-4A72-ABE7-3C043A185AD0 Q45368415-36E15542-E9F9-450A-BB87-E1299C687575 Q46553000-BA745681-55E7-4FEA-BA56-9BC1D3BA4CBF

P2860

Interferon type I gene expression in chronic hepatitis C.

http://www.wikidata.org/entity/Q34328120

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Interferon type I gene expression in chronic hepatitis C.

@ast

Interferon type I gene expression in chronic hepatitis C.

@en

Interferon type I gene expression in chronic hepatitis C.

@nl

type

label

Interferon type I gene expression in chronic hepatitis C.

@ast

Interferon type I gene expression in chronic hepatitis C.

@en

Interferon type I gene expression in chronic hepatitis C.

@nl

prefLabel

Interferon type I gene expression in chronic hepatitis C.

@ast

Interferon type I gene expression in chronic hepatitis C.

@en

Interferon type I gene expression in chronic hepatitis C.

@nl

P1433

Q34328120-51E5FC02-6F3D-40F8-BEE0-0EECE9344E23

P1476

Q34328120-88D636A7-19B9-4809-9C80-7E5C9D5F77A4

P2093

Q34328120-0AC7AE1A-A961-42EA-B0F4-DD9CD2B5C8DC

Q34328120-44BBF50D-1B01-454F-8AC3-D4055E647E2B

Q34328120-4BBED16E-7A52-410A-B453-EB6E2E504264

Q34328120-52ABCEC8-BF1B-4777-9342-896893EE6766

Q34328120-E31B3865-1FE0-4E6B-9A13-5875CC5308D8

P2860

Q34328120-0CACA4BE-5C13-4B70-B49F-798298969C6D

Q34328120-0F744FBE-B9C6-445D-B2CE-D6472EC04230

Q34328120-19848E95-F6BD-4644-9BA9-FA013B05FFF5

Q34328120-2349A80B-0AF3-441D-8845-B72A6FC2E7C3

Q34328120-2E1CEDFD-5BBE-442E-9D05-D24CA3811325

Q34328120-32843BDF-C1E5-4D6D-8D3D-D2B0BBEF6B88

Q34328120-342E33E1-EDF8-45A4-839A-EF1643B1B476

Q34328120-34C24082-144D-4FBD-9815-985BA17E5963

Q34328120-487A3122-7572-48B5-97A5-9F1953D2846C

Q34328120-52E5FE8F-0CE6-40F0-8821-FDB39147DF89

P2888

Q34328120-7A5A8016-94B9-43A3-9886-BD6BB3F8A846

P304

Q34328120-7F0C604B-13A2-43EF-B16A-9DA5B39DDB4C

P31

Q34328120-FD0E3D48-B4BE-4294-AC28-6D5B7E7B72D7

P356

Q34328120-D6192B36-1D08-4423-B797-F26ED95376EC

P433

Q34328120-5E9AA2E6-C4B4-40FB-A979-F53656840828

P478

Q34328120-F2F65033-7311-4D39-BE89-60F70C3545CD

P50

Q34328120-43E3841A-2D61-4DD6-8AF4-8A1E0BFE66D2

Q34328120-78B90712-BD3B-4612-B67C-9531161383C6

P577

Q34328120-F8DD531D-B27B-4CC1-BE95-B1445869D14E

P5875

Q34328120-4C7391C6-A7FD-4DD6-AB48-0A574B2B78D4

P6179

Q34328120-BFD1222D-130C-4EF1-A5D7-B9E4E5A72529

P698

Q34328120-F328A6DC-F266-409D-A77A-1858D92C71E2

P356

LABINVEST.3700135

P1433

Laboratory Investigation

P1476

Interferon type I gene expression in chronic hepatitis C.

@en

P2093

Giuliano Ramadori

http://www.w3.org/2001/XMLSchema#string

Jens-Gerd Scharf

http://www.w3.org/2001/XMLSchema#string

Perdita Wietzke-Braun

http://www.w3.org/2001/XMLSchema#string

Sabine Mihm

http://www.w3.org/2001/XMLSchema#string

Volker Meier

http://www.w3.org/2001/XMLSchema#string

P2860

Functional role of type I and type II interferons in antiviral defense

IL-28, IL-29 and their class II cytokine receptor IL-28R

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization

The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.

Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection.

Effect of alpha interferon on the hepatitis C virus replicon

P2888

labinvest.3700135

P304

1148-1159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.3700135

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Ralf Bartenschlager

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8498791

http://www.w3.org/2001/XMLSchema#string

P6179

1004800167

http://www.w3.org/2001/XMLSchema#string

P698

15208644

http://www.w3.org/2001/XMLSchema#string